Cargando…

Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer

SIMPLE SUMMARY: Neoadjuvant therapy is recommended as standard care for patients with locally advanced resectable esophageal cancer. Neoadjuvant chemotherapy (nCT) and chemoradiotherapy (nCRT) have convincingly been shown to improve the survival rate compared with surgery alone based on the results...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Sicong, Pan, Ziyin, Hao, Xin, Hang, Qinglei, Ding, Yanbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533976/ https://www.ncbi.nlm.nih.gov/pubmed/34680311 http://dx.doi.org/10.3390/cancers13205162

Ejemplares similares

Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2019)

Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
por: Huang, Runkai, et al.
Publicado: (2022)

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2018)

History and current situation of neoadjuvant treatment for locally advanced esophageal cancer
por: Li, Junyi, et al.
Publicado: (2021)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
por: Chen, Fei, et al.
Publicado: (2022)

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2022)

Roles of Integrins in Gastrointestinal Cancer Metastasis
por: Hou, Sicong, et al.
Publicado: (2021)

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
por: Dai, Huiru, et al.
Publicado: (2022)

TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6
por: Hou, Sicong, et al.
Publicado: (2022)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
por: Xu, Lei, et al.
Publicado: (2022)

The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Oh, Dongryul, et al.
Publicado: (2020)

Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis
por: Qin, Hao, et al.
Publicado: (2023)

Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
por: Cheng, Daoan, et al.
Publicado: (2023)

Recent Advances in the Neoadjuvant Treatment of Breast Cancer
por: Rubovszky, Gábor, et al.
Publicado: (2017)

Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Lv, Huilai, et al.
Publicado: (2022)

Principle and progress of radical treatment for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2022)

Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment
por: Fang, Meiqin, et al.
Publicado: (2023)

Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment
por: Li, Jia-yi, et al.
Publicado: (2021)

Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis
por: Fan, Ningbo, et al.
Publicado: (2021)

Neoadjuvant therapy for locally advanced melanoma: new strategies with targeted therapies
por: La Greca, Michele, et al.
Publicado: (2014)

Role of Barium Esophagography in Patients with Locally Advanced Esophageal Cancer: Evaluation of Response to Neoadjuvant Chemoradiotherapy
por: Tsurumaru, Daisuke, et al.
Publicado: (2013)

Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer
por: Cleary, James M., et al.
Publicado: (2016)

Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
por: Chen, Chih-Yi, et al.
Publicado: (2018)

Systemic inflammatory indices predict tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lai, Sicong, et al.
Publicado: (2020)

Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
por: Wang, Ruixi, et al.
Publicado: (2022)

A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Yang, Yalan, et al.
Publicado: (2023)

Recent advances in eosinophilic esophagitis
por: Durrani, Sandy, et al.
Publicado: (2017)

Recent advances in neoadjuvant therapy for breast cancer
por: Potter, David A, et al.
Publicado: (2021)

Organ Preservation Strategies After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Yoo, Ri Na, et al.
Publicado: (2019)

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
por: Yang, Guozhen, et al.
Publicado: (2021)

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
por: He, Wenwu, et al.
Publicado: (2022)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis
por: Wang, Jincheng, et al.
Publicado: (2022)

The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
por: Lv, Huilai, et al.
Publicado: (2023)

Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial
por: Yang, Bo, et al.
Publicado: (2022)

Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study
por: Zhang, Hai, et al.
Publicado: (2023)

Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer
por: Kang, Min Kyu
Publicado: (2023)

Recent advancements in esophageal cancer treatment in Japan
por: Tanaka, Yoshihiro, et al.
Publicado: (2018)

Editorial: Frontiers' research topic “advances in esophageal cancer surgery with neoadjuvant therapies”
por: Shang, Qi-Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kdc35qcec3ds1kvou0jdrgci1d